RYBOX Mutual Fund
RYBOX Mutual Fund
RYBOX Mutual Fund
Rydex Biotechnology Fund Class A
RYBOX Mutual Fund Overview
RYBOX Mutual Fund (Rydex Biotechnology Fund Class A) is managed by Rydex Funds with $17.2M in net assets. RYBOX expense ratio is 1.63%, holding 69 positions across sectors including Health Care. Inception date: 2004-09-01.
RYBOX performance shows a YTD return of 15.02%. The 1-year return is 47.04% and the 5-year return is 5.45%. RYBOX dividend yield stands at 13.20%, paid annually.
RYBOX top holdings include Abbvie Inc. (7.6%), Amgen Inc. (5.1%), Gilead Sciences (4.7%), Nvaesrtex Pharmaceuticals Inc (4.0%), Regeneron Pharmaceuticals, Inc. (2.9%). Go to all RYBOX holdings, RYBOX sectors, or RYBOX dividends.
RYBOX can be compared against other funds. Use RYBOX overlap to find shared positions, or RYBOX vs another fund for a side-by-side view. RYBOX alternatives are available via the screener, along with tax-loss harvesting opportunities.